Dermacyd Teen Care Tangerina Mix - Compatibility

Phase 3

Completed

• Conditions: Hygiene

• Registration Number: NCT00761800
• Lead Sponsor: Sanofi

Brief Summary

The purpose of this study is to demonstrate the absence of irritation potential (primary dermal irritability and cumulated dermal irritability) and allergy (sensibilization) of the product Dermacyd Teen Care Tangerina Mix.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-05
• Primary Completion: 2008-05
• Study Completion: 2008-05
• Study First Submitted: 2008-09-29
• Study First Submitted QC: 2008-09-29
• Study First Posted: 2008-09-30
• Status Verified: 2009-05
• Last Update Submitted: 2009-05-28
• Last Update Posted: 2009-05-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 51

Inclusion Criteria

• Phototype Skin I,II, III e IV
• Integral skin test in the region

Exclusion Criteria

• Lactation or gestation
• Use of Anti-inflammatory and/or immuno-Supression drugs 1 month before the study
• Personal history of atopy
• History of sensitivity or irritation for topic products
• Active cutaneous disease
• Use of new drugs or cosmetics during the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
The absence of primary and accumulated dermal irritability will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale.	Throughout the study

Trial Locations

Locations (1)

Sanofi-Aventis Administrative Office; 🇧🇷 Sao Paulo, Brazil